[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3666 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 3666

   To direct the Secretary of Homeland Security to designate illicit 
   fentanyl as a weapon of mass destruction, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 25, 2023

 Mr. Wenstrup (for himself, Mr. Garbarino, Mr. Tony Gonzales of Texas, 
 Ms. Stefanik, Mr. Harris, Mr. Joyce of Pennsylvania, Mrs. Wagner, and 
Mr. Jackson of Texas) introduced the following bill; which was referred 
     to the Committee on Homeland Security, and in addition to the 
 Committees on the Judiciary, and Foreign Affairs, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL


 
   To direct the Secretary of Homeland Security to designate illicit 
   fentanyl as a weapon of mass destruction, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stop Our Scourge Act of 2023'' or 
the ``SOS Act of 2023''.

SEC. 2. DESIGNATION OF FENTANYL AS A WEAPON OF MASS DESTRUCTION.

    (a) In General.--The Secretary of Homeland Security shall designate 
illicit fentanyl as a weapon of mass destruction for purposes of title 
XIX of the Homeland Security Act of 2002 (6 U.S.C. 590 et seq.).
    (b) Definition.--In this section, the term ``illicit fentanyl'' 
means fentanyl and any analogue thereof that is manufactured, 
distributed, or dispensed, or possessed with intent to manufacture, 
distribute, or dispense, in violation of section 401, 406, or 416 of 
the Controlled Substances Act (21 U.S.C. 841, 846, 856).

SEC. 3. ASSESSMENT REGARDING ILLICIT FENTANYL.

    (a) In General.--The head of the Office of National Drug Control 
Policy, in consultation with the heads of such other Federal agencies 
as the head of the Office of National Drug Control Policy deems 
appropriate, shall conduct an assessment of the following:
            (1) Foreign manufacturing of illicit fentanyl.
            (2) The tools and capabilities across Federal agencies to 
        address trafficking of illicit fentanyl.
            (3) How coordination of Federal efforts to address such 
        trafficking can be improved, including identification of 
        duplicative Federal efforts.
            (4) The capacities of the Mexican military to conduct 
        counterdrug missions with respect to illicit fentanyl.
            (5) The capacities and willingness of the People's Republic 
        of China to curtail the flow of illicit fentanyl, conduct 
        inspections and investigations with respect to illicit 
        fentanyl, screen for illicit fentanyl at ports of exit, 
        implement ``know-your-customer'' standards, and hold 
        traffickers of illicit fentanyl accountable.
            (6) Illicit fentanyl being trafficked into the United 
        States from Mexico, including the purity, formulation, and 
        weight of the illicit fentanyl.
    (b) Timing; Report.--Not later than 180 days after the date of 
enactment of this Act, the head of the Office of National Drug Control 
Policy shall--
            (1) complete the assessment required by subsection (a); and
            (2) submit a report to the Congress on the results of such 
        assessment.
    (c) Definition.--In this section, the term ``illicit fentanyl'' 
means fentanyl and any analogue or precursor thereof that is 
manufactured, distributed, or dispensed, or possessed with intent to 
manufacture, distribute, or dispense, in violation of section 401, 406, 
or 416 of the Controlled Substances Act (21 U.S.C. 841, 846, 856).
                                 <all>